Shanghai Fudan Fuhua Pharmaceutical

Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. (also known as Shanghai Fudan Forward Pharmaceutical) is a Chinese pharmaceutical company specializing in the research, development, manufacturing, and commercialization of chemical drugs, modern traditional Chinese medicines, and generic pharmaceuticals. Originally founded as the Shanghai Medical University Red Flag Pharmaceutical Factory in 1958, the company was restructured and renamed after its acquisition by Shanghai Fudan Fuhua Technology Co., Ltd. in 2001. Its core product portfolio focuses on specialty therapeutic areas including oncology, neurology, digestive systems, and cardiovascular diseases, with prominent products such as reduced glutathione for injection, huperzine A tablets, tamoxifen citrate tablets, and bicalutamide tablets. The company operates large-scale manufacturing bases in Shanghai Minhang and Jiangsu Nantong, moving towards an integrated raw material and formulation production model.